Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study

Clicks: 367
ID: 118301
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The in vitro activity of gemifloxacin, a new fluoroquinolone, was compared to three marketed fluoroquinolones; ciprofloxacin, levofloxacin and ofloxacin against over 4,000 recent clinical isolates covering 29 species isolated in the United States and Canada between 1997-1999. Based on MIC(90)s, gemi …
Reference Key
dj1970diagnosticcomparative Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hoban DJ;Bouchillon SK;Johnson JL;Zhanel GG;Butler DL;Miller LA;Poupard JA; ;;
Journal Diagnostic microbiology and infectious disease
Year 1970
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11448564
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't united states / epidemiology Comparative Study microbial sensitivity tests gram-negative bacterial infections / epidemiology gram-negative bacterial infections / microbiology anti-infective agents / pharmacology* fluoroquinolones* gram-negative bacteria / drug effects* population surveillance* canada / epidemiology pmid:11448564 doi:10.1016/s0732-8893(01)00241-3 d j hoban s k bouchillon gemifloxacin surveillance study research group gemifloxacin gram-positive bacteria / drug effects* gram-positive bacterial infections / epidemiology gram-positive bacterial infections / microbiology naphthyridines / pharmacology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.